Skip to main content

Advertisement

SpringerLink
Log in

ASO Author Reflections: Future Prospects of Neoadjuvant Chemotherapy for Gastric Cancer

  • ASO Author Reflections
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Tsuburaya A, Mizusawa J, Tanaka Y, et al. Neoadjuvant chemotherapy with S-1 and cisplatin followed by D2 gastrectomy with para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis. Br J Surg. 2014;101(6):653–60.

    Article  CAS  Google Scholar 

  2. Iwasaki Y, Terashima M, Mizusawa J, et al. Randomized phase III trial of gastrectomy with or without neoadjuvant S-1 plus cisplatin for type 4 or large type 3 gastric cancer: Japan Clinical Oncology Group study (JCOG0501). J Clin Oncol. 2018;36(15 suppl):4046

    Article  Google Scholar 

  3. Kodera Y, Yoshida K, Kochi M, et al. A randomized phase III study comparing S-1 plus docetaxel with S-1 alone as a postoperative adjuvant chemotherapy for curatively resected stage III gastric cancer (JACCRO GC-07 trial). J Clin Oncol. 2018;36(15 suppl):4007

    Article  Google Scholar 

  4. Kano M, Hayano K, Hayashi H, et al. Survival benefit of neoadjuvant chemotherapy with S-1 plus docetaxel for locally advanced gastric cancer: a propensity score-matched analysis. Ann Surg Oncol. 2019;26:1805–13.

    Article  Google Scholar 

  5. Yamada Y, Boku N, Mizusawa J, et al. Phase III study comparing triplet chemotherapy with S-1 and cisplatin plus docetaxel versus doublet chemotherapy with S-1 and cisplatin for advanced gastric cancer (JCOG1013). J Clin Oncol. 2018;36(15 suppl):4009

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Frontier Surgery, Chiba University, Chiba, Japan

    Masayuki Kano MD, PhD & Hisahiro Matsubara MD, PhD

Authors
  1. Masayuki Kano MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hisahiro Matsubara MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Masayuki Kano MD, PhD.

Ethics declarations

Disclosures

The author reports no conflicts of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

ASO Author Reflections is a brief invited commentary on the article, “Survival Benefit of Neoadjuvant Chemotherapy with S-1 Plus Docetaxel for Locally Advanced Gastric Cancer: A Propensity Score-Matched Analysis,” Ann Surg Oncol. 2019;26:1805–13.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kano, M., Matsubara, H. ASO Author Reflections: Future Prospects of Neoadjuvant Chemotherapy for Gastric Cancer. Ann Surg Oncol 27 (Suppl 3), 721–722 (2020). https://doi.org/10.1245/s10434-019-07862-2

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-019-07862-2

Search

Navigation